全国免费电话:400-668-6834 -- 仅限中国地区 -- |
在线订购:QQ: 4006686834 电话订购:021-68591985 邮件订购:info@selleck.cn 我们也提供销售人员上门服务 |
技术支持电话:400-168-6834 我们将于一个工作日与您联系 |
别名 | PB04 | 储存条件 (自收到货起) |
3年 / -20°C / 粉状 1年 / -80°C / 溶于溶剂 |
|
化学式 | C24H22F2N6O3S |
|||
分子量 | 512.53 | CAS号 | 1393465-84-3 | |
Solubility (25°C)* | 体外 | DMSO | 100 mg/mL (195.11 mM) | |
Water | Insoluble | |||
Ethanol | Insoluble | |||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
产品描述 | PLX7904,又名PB04,是一种有效的、选择性RAF抑制剂。它能够在BRAF突变的黑色素瘤细胞中有效地抑制ERK1/2的激活,但在表达突变RAS的细胞中并不过度激活ERK1/2。 | |
---|---|---|
靶点 |
|
|
体外研究 | PLX7940在携有BRAF突变的黑色素瘤细胞中有效地抑制ERK1/2的激活,但在表达RAS的突变细胞株中不会过度激活ERK1/2。PLX7904在携带有突变N-RAS的耐vemurafenib的细胞中促进凋亡,抑制细胞进入S期和减少贴壁不依赖性生长[1][2]。 | |
体内研究 | PLX7904抑制COLO205移植瘤生长[1]。 |
细胞实验 | 细胞系 | WM793, WM115, WM9, WM278, WM1346, WM1366, WM1361A, Sbcl2, 1205Lu, A375, SK-MEL 24, SKMEL-2, and SK-MEL 207细胞 |
---|---|---|
浓度 | 0, 0.5, 1, 5 μM | |
处理时间 | 24h | |
方法 | 细胞用不同浓度(0, 0.05, 0.1, 1, 5 μM)的PB04(PLX7904)处理24小时。细胞裂解产物用来进行Werstern blotting分析,抗体为phospho-MEK1/2, total MEK1/2, phospho-ERK1/2 and total ERK1/2。 |
|
Oncogenic BRAF induces whole-genome doubling through suppression of cytokinesis [ Nat Commun, 2022, 13(1):4109] | PubMed: 35840569 |
Increased IRF9-STAT2 signaling leads to adaptive resistance toward targeted therapy in melanoma by restraining GSDME-dependent pyroptosis [ J Invest Dermatol, 2022, S0022-202X(22)00096-3] | PubMed: 35148998 |
A Cell-Based MAPK Reporter Assay Reveals Synergistic MAPK Pathway Activity Suppression by MAPK Inhibitor Combination in BRAF-driven Pediatric Low-Grade Glioma Cells [ Mol Cancer Ther, 2020, 25;molcanther.1021.2019] | PubMed: 32451331 |
Analyses of the oncogenic BRAFD594G variant reveal a kinase-independent function of BRAF in activating MAPK signaling. [ J Biol Chem, 2020, 295(8):2407-2420] | PubMed: 31929109 |
Distinct Binding Preferences between Ras and Raf Family Members and the Impact on Oncogenic Ras Signaling. [ Mol Cell, 2019, 76(6):872-884] | PubMed: 31606273 |
Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers [ Cell Rep, 2019, 29(1):118-134] | PubMed: 31577942 |
Identification and characterization of a BRAF fusion oncoprotein with retained autoinhibitory domains. [ Oncogene, 2019, 10.1038/s41388-019-1021-] | PubMed: 31558800 |
Identifying the ErbB/MAPK Signaling Cascade as a Therapeutic Target in Canine Bladder Cancer [ Mol Pharmacol, 2019, 96(1):36-46] | PubMed: 31048548 |
Biochemical Characterization of Full-Length Oncogenic BRAFV600E together with Molecular Dynamics Simulations Provide Insight into the Activation and Inhibition Mechanisms of RAF Kinases. [ Chembiochem, 2019, 10.1002/cbic.201900266] | PubMed: 31152574 |
SOX2‐mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma [Hüser L Int J Cancer, 2018, 143(12):3131-3142] | PubMed: 29905375 |
特定的存储和包装每个产品的信息在产品说明书上都有注明。大多数Selleck产品,在推荐的条件下存储可稳定保存两年。产品有时建议的储存温度不同,大多数建议储存在-20°C,抑制剂属于化学试剂,可在常温下运输储存两周左右。即使如此,我们保证产品的出货量将保持产品质量的条件下,一般都会放入冰袋。望阁下收到产品后,请按照产品数据表建议适当存储。
如果需要长期保存,请于零下二十度低温保存。禁止用于人体及治疗!
退换货政策
Selleck提供宽松的退换货承诺,努力为您营造最优的购物体验。每个订单Selleck只提供一次退换货服务,为了确保您的权益,请您仔细阅读以下内容:
1. 请在返还样品之前事先与我们取得联系,以确保产品是直接向我们或者当地代理商购买的;
2. 自收到货物起七天内,如因运输过程有问题或其他任何问题,您可以提出退换货要求;自收到货物起365天内,如因产品质量有问题,您可以提出退换货要求。
3. 请使用我们的快递账号进行退换货,您无需为此承担任何费用。
4. 如您已收到由Selleck开具的发票,则办理退货或订单金额发生变更的换货时,请将发票随商品一同返还给Selleck。请您妥善保管发票,如发票丢失,将无法办理退换货手续。
5. 对于合理的退换货要求,我们会在5个工作日内处理完成您的款项退还和新换货物的运输等,请耐心等待。